Zentalis® Pharmaceuticals, Inc. announced that on December 1, 2023, the Compensation Committee of Zentalis’ Board of Directors granted non-qualified stock options to purchase an aggregate of 42,000 shares of the Company’s common stock and 28,000 restricted stock units to one newly hired employee.
December 1, 2023
· 2 min read